Neri D - Search Results

1

Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain A of fibronectin.

Franz M, Doll F, Grün K, Richter P, Köse N, Ziffels B, Schubert H, Figulla HR, Jung C, Gummert J, Renner A, Neri D, Berndt A. Franz M, et al. Among authors: neri d. Int J Cardiol. 2015 Sep 15;195:311-22. doi: 10.1016/j.ijcard.2015.05.144. Epub 2015 May 29. Int J Cardiol. 2015. PMID: 26056964

2

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix.

Carnemolla B, Borsi L, Balza E, Castellani P, Meazza R, Berndt A, Ferrini S, Kosmehl H, Neri D, Zardi L. Carnemolla B, et al. Among authors: neri d. Blood. 2002 Mar 1;99(5):1659-65. doi: 10.1182/blood.v99.5.1659. Blood. 2002. PMID: 11861281 Free article.

3

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

Halin C, Rondini S, Nilsson F, Berndt A, Kosmehl H, Zardi L, Neri D. Halin C, et al. Among authors: neri d. Nat Biotechnol. 2002 Mar;20(3):264-9. doi: 10.1038/nbt0302-264. Nat Biotechnol. 2002. PMID: 11875427

4

Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins.

Halin C, Niesner U, Villani ME, Zardi L, Neri D. Halin C, et al. Among authors: neri d. Int J Cancer. 2002 Nov 10;102(2):109-16. doi: 10.1002/ijc.10674. Int J Cancer. 2002. PMID: 12385005

5

Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.

Halin C, Gafner V, Villani ME, Borsi L, Berndt A, Kosmehl H, Zardi L, Neri D. Halin C, et al. Among authors: neri d. Cancer Res. 2003 Jun 15;63(12):3202-10. Cancer Res. 2003. PMID: 12810649

6

Selective targeted delivery of TNFalpha to tumor blood vessels.

Borsi L, Balza E, Carnemolla B, Sassi F, Castellani P, Berndt A, Kosmehl H, Biro A, Siri A, Orecchia P, Grassi J, Neri D, Zardi L. Borsi L, et al. Among authors: neri d. Blood. 2003 Dec 15;102(13):4384-92. doi: 10.1182/blood-2003-04-1039. Epub 2003 Aug 21. Blood. 2003. PMID: 12933583 Free article.

7

Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin.

Matter CM, Schuler PK, Alessi P, Meier P, Ricci R, Zhang D, Halin C, Castellani P, Zardi L, Hofer CK, Montani M, Neri D, Lüscher TF. Matter CM, et al. Among authors: neri d. Circ Res. 2004 Dec 10;95(12):1225-33. doi: 10.1161/01.RES.0000150373.15149.ff. Epub 2004 Nov 11. Circ Res. 2004. PMID: 15539632

8

Engineered vascular-targeting antibody-interferon-gamma fusion protein for cancer therapy.

Ebbinghaus C, Ronca R, Kaspar M, Grabulovski D, Berndt A, Kosmehl H, Zardi L, Neri D. Ebbinghaus C, et al. Among authors: neri d. Int J Cancer. 2005 Aug 20;116(2):304-13. doi: 10.1002/ijc.20952. Int J Cancer. 2005. PMID: 15800913

9

Fibronectin as target for tumor therapy.

Kaspar M, Zardi L, Neri D. Kaspar M, et al. Among authors: neri d. Int J Cancer. 2006 Mar 15;118(6):1331-9. doi: 10.1002/ijc.21677. Int J Cancer. 2006. PMID: 16381025 Review.

10

Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder.

Berndt A, Anger K, Richter P, Borsi L, Brack S, Silacci M, Franz M, Wunderlich H, Gajda M, Zardi L, Neri D, Kosmehl H. Berndt A, et al. Among authors: neri d. J Cancer Res Clin Oncol. 2006 Aug;132(8):537-46. doi: 10.1007/s00432-006-0106-8. Epub 2006 May 31. J Cancer Res Clin Oncol. 2006. PMID: 16788848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

676 results

Search Page

Filters